Literature DB >> 16293798

Endothelial nitric oxide synthase: host defense enzyme of the endothelium?

Ton J Rabelink1, Thomas F Luscher.   

Abstract

This article explores the physiology of superoxide generation by endothelial nitric oxide synthase (eNOS), the so-called "uncoupled" state of the enzyme. The fact that this alternative chemistry of the eNOS enzyme is evolutionary strongly conserved, suggests that it may play a physiological role. It is proposed that this uncoupled state may contribute to defense against infections. As the switch from NO production to reactive oxygen species by eNOS is also the final common pathway in atherogenesis, the uncoupling of eNOS further builds on the hypothesis that atherogenesis is driven by cellular mechanisms that originally serve host defense. The central role of uncoupled eNOS in redox signaling in the endothelium may open up new avenues for therapy to prevent atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293798     DOI: 10.1161/01.ATV.0000196554.85799.77

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

Review 1.  The glycocalyx--linking albuminuria with renal and cardiovascular disease.

Authors:  Ton J Rabelink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2015-10-13       Impact factor: 28.314

2.  Nitric oxide-generating silicone as a blood-contacting biomaterial.

Authors:  Kagya A Amoako; Keith E Cook
Journal:  ASAIO J       Date:  2011 Nov-Dec       Impact factor: 2.872

3.  Simvastatin combined with nifedipine enhances endothelial cell protection by inhibiting ROS generation and activating Akt phosphorylation.

Authors:  Xiao-niao Chen; Jun Xu; Zhe Feng; Ming Fan; Jing-yao Han; Zhuo Yang
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

Review 4.  Endothelial activation and circulating markers of endothelial activation in kidney disease.

Authors:  Ton J Rabelink; Hetty C de Boer; Anton J van Zonneveld
Journal:  Nat Rev Nephrol       Date:  2010-05-25       Impact factor: 28.314

5.  Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.

Authors:  Hans Fischer; Nataliya Lutay; Bryndís Ragnarsdóttir; Manisha Yadav; Klas Jönsson; Alexander Urbano; Ahmed Al Hadad; Sebastian Rämisch; Petter Storm; Ulrich Dobrindt; Ellaine Salvador; Diana Karpman; Ulf Jodal; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

6.  Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

Authors:  Daria K Moaveni; Erin M Lynch; Cathy Luke; Vikram Sood; Gilbert R Upchurch; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

7.  Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.

Authors:  W S Waring; J A McKnight; D J Webb; S R J Maxwell
Journal:  Diabetologia       Date:  2007-10-10       Impact factor: 10.122

Review 8.  Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice.

Authors:  Victor W T Liu; Paul L Huang
Journal:  Cardiovasc Res       Date:  2008-01       Impact factor: 10.787

Review 9.  Fibrosis and heart failure.

Authors:  Ana Maria Segura; O H Frazier; L Maximilian Buja
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

10.  Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.

Authors:  Guolian Li; Juan-Pablo Del Rincon; Linda A Jahn; Yangsong Wu; Bruce Gaylinn; Michael O Thorner; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.